Trial finds over-the-counter nasal sprays could reduce RTIs and antibiotic use
Affecting parts of the body involving breathing, RTIs impact one in five people in England
Read Moreby Jen Brogan | Jul 15, 2024 | News | 0
Affecting parts of the body involving breathing, RTIs impact one in five people in England
Read Moreby Jen Brogan | Apr 11, 2024 | News | 0
RTIs account for around 60% of global antibiotic prescribing and are a key driver of AMR
Read Moreby John Pinching | Nov 17, 2022 | News | 0
The challenge of resistant infections will require new antibiotics according to the ABPI
Read Moreby Selina McKee | Nov 2, 2020 | News | 0
It is hoped that findings from the NIHR-funded trial will help better inform treatment decisions
Read Moreby Selina McKee | Jun 18, 2020 | News | 0
The scheme could give NHS patients access to new antibiotics as early as 2022
Read Moreby Anna Smith | Jan 20, 2020 | News | 0
Of the 60 products in development, very few seem to show benefit over existing treatments.
Read Moreby Anna Smith | Aug 23, 2019 | News | 0
Data showed that those who had been given at least two previous courses were 32% more likely to fail to respond to a subsequent course.
Read Moreby Anna Smith | Jul 22, 2019 | News | 0
NICE reviewed a BMJ study and determined that the findings suggest that guidance on antibiotic use is not being implemented as well as it could be in all areas which may lead to antibiotic overuse.
Read Moreby Anna Smith | Jul 19, 2019 | News | 0
The antibiotics, known as class II polyketides, are also naturally produced by soil bacteria and have antimicrobial properties.
Read Moreby Anna Smith | Mar 5, 2019 | News | 0
A BBC reporter has discovered an online trade of illegal drugs for STIs.
Read Moreby Selina McKee | Jul 11, 2018 | News | 0
The government has launched a £10 million research competition to encourage the development of novel approaches to combating antimicrobial resistance and improving infection prevention and control.
Read Moreby Selina McKee | Jul 10, 2018 | News | 0
The National Institute for Health and Care Excellence is advising healthcare professionals to restrict use of antibiotics for chronic obstructive pulmonary disease (COPD).
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
